Bentham Science Logo

Track Your Manuscript:

Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access


Current Cancer Drug Targets, Volume 18 - Number 4

Review Article

Recent Updates on the Therapeutic Potential of HER2 Tyrosine Kinase Inhibitors for the Treatment of Breast Cancer

, 18(4): 306 - 327

Heena Singla, Anjana Munshi*, Raja Paramjit Singh Banipal and Vinod Kumar*

DOI: 10.2174/1568009617666170623122213

Review Article

Involvement of CD24 in Multiple Cancer Related Pathways Makes It an Interesting New Target for Cancer Therapy

, 18(4): 328 - 336

Shirin Eyvazi, Bahram Kazemi, Siavoush Dastmalchi* and Mojgan Bandehpour*

DOI: 10.2174/1570163814666170818125036

Review Article

Synthetic Lethality: From Research to Precision Cancer Nanomedicine

, 18(4): 337 - 346

Anuradha Gupta, Anas Ahmad, Aqib Iqbal Dar and Rehan Khan*

DOI: 10.2174/1568009617666170630141931

Review Article

Cell-derived Exosomes as Promising Carriers for Drug Delivery and Targeted Therapy

, 18(4): 347 - 354

Xinyi Wang, Haiyang Zhang, Haiou Yang, Ming Bai, Tao Ning, Shuang Li, Jialu Li, Ting Deng, Guoguang Ying* and Yi Ba*

DOI: 10.2174/1568009617666170710120311

Review Article

The PI3K Pathway at the Crossroads of Cancer and the Immune System: Strategies for Next Generation Immunotherapy Combinations

, 18(4): 355 - 364

Dearbhaile C. Collins, Maxime Chenard-Poirier and Juanita S. Lopez*

DOI: 10.2174/1568009617666170927114440

Research Article

Chemosensitizing Activity of Histone Deacetylases Inhibitory Cyclic Hydroxamic Acids for Combination Chemotherapy of Lymphatic Leukemia

, 18(4): 365 - 371

Denis V. Mishchenko, Margarita E. Neganova, Elena N. Klimanova, Tatyana E. Sashenkova, Sergey G. Klochkov, Elena F. Shevtsova, Igor V. Vystorop, Vadim V. Tarasov, Vladimir N. Chubarev, Anna N. Samsonova, Ghulam Md Ashraf, George Barreto, Nagendra Sastry Yarla and Gjumrakch Aliev*

DOI: 10.2174/1568009617666170623104030

Research Article

DNA Fragmentation, Cell Cycle Arrest, and Docking Study of Novel Bis Spiro-cyclic 2-oxindole of Pyrimido[4,5-b]quinoline-4,6-dione Derivatives Against Breast Carcinoma

, 18(4): 372 - 381

Magda F. Mohamed, Amr Mohamed Abdelmoniem, Ahmed H.M. Elwahy* and Ismail A. Abdelhamid*

DOI: 10.2174/1568009617666170630143311

Research Article

FOXP2 Promotes Tumor Proliferation and Metastasis by Targeting GRP78 in Triple-negative Breast Cancer

, 18(4): 382 - 389

Jiali Wu, Peng Liu, Hailin Tang, Zeyu Shuang, Qingsheng Qiu, Lijuan Zhang, Cailu Song, Lingrui Liu, Xiaoming Xie* and Xiangsheng Xiao*

DOI: 10.2174/1568009618666180131115356

Research Article

Neoisoliquiritigenin Inhibits Tumor Progression by Targeting GRP78-β- catenin Signaling in Breast Cancer

, 18(4): 390 - 399

Hailin Tang, Fu Peng, Xiaojia Huang, Xinhua Xie, Bo Chen, Jiangang Shen, Fei Gao, Jieshu You, Xiaoming Xie* and Jianping Chen*

DOI: 10.2174/1568009617666170914155355


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.



Related Journals

Related eBooks

eBooks Catalog